A Mini Review on the Contribution of the Anterior Cingulate Cortex in the Risk of Psychosis in 22q11.2 Deletion Syndrome

Frontiers in Psychiatry
Maria C PadulaStephan Eliez

Abstract

22q11.2 deletion syndrome (22q11DS) is a neurogenetic disorder that causes a high risk of developing schizophrenia, thus representing a unique model for the investigation of biomarkers of psychosis. Cognitive and clinical risk factors have been identified as reliable predictors of schizophrenia in patients with 22q11DS and are currently used in the clinical practice. However, biomarkers based on neuroimaging are still lacking, mainly because of the analytic approaches adopted so far, which are almost uniquely based on the comparison of 22q11DS patients with healthy controls. Such comparisons do not take into account the heterogeneity within patients with 22q11DS, who indeed show various clinical manifestations. More recently, a number of studies compared measures of brain morphology and connectivity between patients with 22q11DS with different symptomatic profiles. The aim of this short review is to highlight the brain alterations found in patients with 22q11DS fulfilling ultra-high risk (UHR) criteria. Findings point to alterations in brain morphology and connectivity in frontal brain regions, and in particular in the anterior cingulate cortex, in patients with 22q11DS presenting UHR symptoms. These alterations may represent v...Continue Reading

References

Sep 9, 1995·Lancet·P McGuffinA E Farmer
Oct 26, 1999·Archives of General Psychiatry·K C MurphyM J Owen
May 29, 2000·Trends in Cognitive Sciences·G BushM I Posner
Mar 10, 2001·Clinical Pharmacology and Therapeutics·UNKNOWN Biomarkers Definitions Working Group.
Jun 5, 2003·The British Journal of Psychiatry : the Journal of Mental Science·Murat YücelChristos Pantelis
Aug 29, 2003·The American Journal of Psychiatry·Anne S BassettRosanna Weksberg
Jun 7, 2006·Schizophrenia Research·Eva W C ChowAnne S Bassett
Nov 14, 2006·Biological Psychiatry·Stefan J BorgwardtPhilip K McGuire
Feb 3, 2007·The British Journal of Psychiatry : the Journal of Mental Science·Paul AllenPhilip K McGuire
Sep 22, 2007·Neuroscience and Biobehavioral Reviews·Paul AllenAndrè Aleman
Mar 24, 2010·Acta Neuropathologica·Martin BrüneElisabeth Petrasch-Parwez
Dec 14, 2011·Trends in Neurosciences·David A LewisDavid W Volk
Oct 26, 2013·Journal of the American Academy of Child and Adolescent Psychiatry·Doron GothelfStephan Eliez
Mar 1, 2014·The American Journal of Psychiatry·Maude SchneiderUNKNOWN International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome
Feb 26, 2015·JAMA Psychiatry·Jacob A S VorstmanUNKNOWN International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome
Jun 19, 2015·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Lily VanAnne S Bassett
Jan 15, 2016·Nature Reviews. Neuroscience·Giles E Hardingham, Kim Q Do
Aug 16, 2016·Journal of Neural Transmission·Yael Midbari KufertDoron Gothelf
Oct 8, 2016·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Maude SchneiderStephan Eliez
Sep 3, 2017·Psychiatry Research. Neuroimaging·David R RoalfRaquel E Gur
Jan 18, 2018·Psychological Medicine·Maria Carmela PadulaStephan Eliez
May 8, 2018·Biological Psychiatry : Cognitive Neuroscience and Neuroimaging·Corrado SandiniStephan Eliez

❮ Previous
Next ❯

Related Concepts

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.